Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial

AIM: To perform a post hoc analysis of the FIGHT trial, evaluating the effect of liraglutide (vs. placebo) on the totality of events in patients with heart failure with reduced ejection fraction (HFrEF). MATERIALS AND METHODS: FIGHT was a double‐blind randomized controlled trial (RCT) that studied l...

Descripción completa

Detalles Bibliográficos
Autores principales: Neves, João Sérgio, Vasques‐Nóvoa, Francisco, Borges‐Canha, Marta, Leite, Ana Rita, Sharma, Abhinav, Carvalho, Davide, Packer, Milton, Zannad, Faiez, Leite‐Moreira, Adelino, Ferreira, João Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742170/
https://www.ncbi.nlm.nih.gov/pubmed/36082522
http://dx.doi.org/10.1111/dom.14862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742170/
https://www.ncbi.nlm.nih.gov/pubmed/36082522
http://dx.doi.org/10.1111/dom.14862

Ejemplares similares